(2S)-2-[1-[6-[2-(hydroxymethyl)morpholin-4-yl]pyrimidin-4-yl]indazol-6-yl]spiro[2.2]pentane-2-carbonitrile
C22H22N6O2 — CID 156518838
Data last refreshed: (MolForge compound catalog, from PubChem)
About (2S)-2-[1-[6-[2-(hydroxymethyl)morpholin-4-yl]pyrimidin-4-yl]indazol-6-yl]spiro[2.2]pentane-2-carbonitrile
(2S)-2-[1-[6-[2-(hydroxymethyl)morpholin-4-yl]pyrimidin-4-yl]indazol-6-yl]spiro[2.2]pentane-2-carbonitrile (PubChem CID 156518838) has the molecular formula C22H22N6O2 and a molecular weight of 402.46 g/mol. Its IUPAC name is (2S)-2-[1-[6-[2-(hydroxymethyl)morpholin-4-yl]pyrimidin-4-yl]indazol-6-yl]spiro[2.2]pentane-2-carbonitrile.
Molecular Properties
| Compound Name | (2S)-2-[1-[6-[2-(hydroxymethyl)morpholin-4-yl]pyrimidin-4-yl]indazol-6-yl]spiro[2.2]pentane-2-carbonitrile |
|---|---|
| PubChem CID | 156518838 |
| Molecular Formula | C22H22N6O2 |
| Molecular Weight | 402.46 g/mol |
| Exact Mass | 402.18 |
| IUPAC Name | (2S)-2-[1-[6-[2-(hydroxymethyl)morpholin-4-yl]pyrimidin-4-yl]indazol-6-yl]spiro[2.2]pentane-2-carbonitrile |
| SMILES | N#C[C@@]1(c2ccc3cnn(-c4cc(N5CCOC(CO)C5)ncn4)c3c2)CC12CC2 |
| InChI | InChI=1S/C22H22N6O2/c23-13-22(12-21(22)3-4-21)16-2-1-15-9-26-28(18(15)7-16)20-8-19(24-14-25-20)27-5-6-30-17(10-27)11-29/h1-2,7-9,14,17,29H,3-6,10-12H2/t17?,22-/m1/s1 |
| InChIKey | WXHQENLWWKVPPA-IVAFLUGOSA-N |
| XLogP | 1.96 |
| TPSA | 100.09 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 30 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 402.46 |
| LogP ≤ 5 | 1.96 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 156518838 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.